Related Experiment Video
Updated: Apr 12, 2026

Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and Modeling
Published on: May 31, 2017
The MDM4/MDM2-p53-IGF1 axis controls axonal regeneration, sprouting and functional recovery after CNS injury
Yashashree Joshi1, Marília Grando Sória2, Giorgia Quadrato3
11 Laboratory for NeuroRegeneration and Repair, Centre for Neurology, Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany 2 Graduate School for Cellular and Molecular Neuroscience, University of Tuebingen, Tuebingen, Germany 3 German Centre for Neurodegenerative Diseases (DZNE), Tuebingen, Germany.
Abstract:
Regeneration of injured central nervous system axons is highly restricted, causing neurological impairment. To date, although the lack of intrinsic regenerative potential is well described, a key regulatory molecular mechanism for the enhancement of both axonal regrowth and functional recovery after central nervous system injury remains elusive. While ubiquitin ligases coordinate neuronal morphogenesis and connectivity during development as well as after axonal injury, their role specifically in axonal regeneration is unknown. Following a bioinformatics network analysis combining ubiquitin ligases with previously defined axonal regenerative proteins, we found a triad composed of the ubiquitin ligases MDM4, MDM2 and the transcription factor p53 (encoded by TP53) as a putative central signalling complex restricting the regeneration program. Indeed, conditional deletion of MDM4 or pharmacological inhibition of MDM2/p53 interaction in the eye and spinal cord promote axonal regeneration and sprouting of the optic nerve after crush and of supraspinal tracts after spinal cord injury. The double conditional deletion of MDM4-p53 as well as MDM2 inhibition in p53-deficient mice blocks this regenerative phenotype, showing its dependence upon p53. Genome-wide gene expression analysis from ex vivo fluorescence-activated cell sorting in MDM4-deficient retinal ganglion cells identifies the downstream target IGF1R, whose activity and expression was found to be required for the regeneration elicited by MDM4 deletion. Importantly, we demonstrate that pharmacological enhancement of the MDM2/p53-IGF1R axis enhances axonal sprouting as well as functional recovery after spinal cord injury. Thus, our results show MDM4-MDM2/p53-IGF1R as an original regulatory mechanism for CNS regeneration and offer novel targets to enhance neurological recovery.media-1vid110.1093/brain/awv125_video_abstractawv125_video_abstract.
Insights
Researchers identified a molecular pathway involving MDM4, MDM2, p53, and IGF1R that restricts central nervous system (CNS) axon regeneration. Inhibiting this pathway promotes axonal regrowth and functional recovery after CNS injury.
Area of Science:
- Neuroscience
- Molecular Biology
- Regenerative Medicine
Background:
- Central nervous system (CNS) axon regeneration is limited after injury, leading to persistent neurological deficits.
- The molecular mechanisms governing CNS regenerative potential remain incompletely understood.
- Ubiquitin ligases are known regulators of neuronal development and response to injury, but their role in axonal regeneration is unexplored.
Purpose of the Study:
- To identify novel molecular regulators of CNS axonal regeneration.
- To investigate the role of ubiquitin ligases in the regenerative response after CNS injury.
- To explore therapeutic targets for enhancing neurological recovery.
Main Methods:
- Bioinformatics network analysis to identify potential signaling complexes.
- Conditional gene deletion (MDM4, p53) in mouse models.
- Pharmacological inhibition of protein-protein interactions (MDM2/p53).
- Axonal regeneration assays in optic nerve and spinal cord injury models.
- Genome-wide gene expression analysis (RNA-seq) and fluorescence-activated cell sorting (FACS).
- Functional recovery assessments after spinal cord injury.
Main Results:
- A signaling triad of MDM4, MDM2, and p53 was identified as a negative regulator of CNS regeneration.
- Conditional deletion of MDM4 or inhibition of MDM2/p53 interaction promoted axonal regeneration and sprouting.
- Regeneration was dependent on p53, and IGF1R was identified as a key downstream target.
- Pharmacological enhancement of the MDM2/p53-IGF1R axis improved axonal sprouting and functional recovery post-spinal cord injury.
Conclusions:
- The MDM4-MDM2/p53-IGF1R axis represents a novel regulatory mechanism restricting CNS regeneration.
- Targeting this pathway offers a promising therapeutic strategy for promoting axonal regrowth and functional recovery after CNS injuries.
- This discovery opens new avenues for developing treatments for neurological impairments.
Related Concept Videos
Neurogenesis and Regeneration of Nervous Tissue
Abnormal Proliferation

